Indices of Cholesterol Metabolism and Relative Responsiveness to Ezetimibe and Simvastatin | Zendy

Susan G. Lakoski | Zendy; Fang Xu | Zendy; Gloria Lena Vega | Zendy; Scott M. Grundy | Zendy; Manisha Chandalia | Zendy; Chun Sing Lam | Zendy; Robert S. Lowe | Zendy; Michael Stepanavage | Zendy; MingShyan Lin | Zendy; Jonathan C. Cohen | Zendy; Helen H. Hobbs | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Indices of Cholesterol Metabolism and Relative Responsiveness to Ezetimibe and Simvastatin

Author(s) -

Susan G. Lakoski,

Fang Xu,

Gloria Lena Vega,

Scott M. Grundy,

Manisha Chandalia,

Chun Sing Lam,

Robert S. Lowe,

Michael Stepanavage,

MingShyan Lin,

Jonathan C. Cohen,

Helen H. Hobbs

Publication year - 2009

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2009-1952

Subject(s) - ezetimibe , simvastatin , lathosterol , pcsk9 , campesterol , placebo , cholesterol , medicine , endocrinology , statin , pharmacology , crossover study , lipoprotein , chemistry , sterol , ldl receptor , alternative medicine , pathology

The level and duration of exposure to circulating low-density lipoprotein-cholesterol (LDL-C) are major contributors to coronary atherosclerosis. Therefore, optimal prevention will require long-term LDL-C reduction, making it important to select the most effective agent for each individual.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research